Single award · contract

Contract 75A50126C00010

Award ID: 75A50126C00010

FY2026 ended Sep 30 · data still posting · data as of 2026-11-01†

† DoD contract data posts to USAspending about 90 days after award.

A single federal award, with both ends of the trail linked.

$96.1M
Total award value

Award 75A50126C00010 is a contract from the Department of Health and Human Services, $96.1M obligated, FY2026 to FY2035. The work is performed in Virginia. It is classified as NAICS 541714 (Research and Development in Biotechnology (except Nanobiotechnology)) and PSC AN11 (Health R&D Services; Health Care Services; Basic Research). Source

Description

This Acquisition Will Allow BARDA to Invest Project Bioshield Funds for Late-Stage Clinical Development, Regulatory Approval for 2-PAM Autoinjectors (as a Drug/Device Combination Product) to Treat Organophosphate (Op) Poisoning, Including Nerve Agent

Award details

Award typeContract
PIID75A50126C00010
Action date2026
Period99 mo
RecipientOutside our Phase 1 contractor set: see methodology
Place of performanceVirginia →
Competed?Not recordedSource
Total (exact)$96,058,494

More from Department of Health and Human Services

Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.